Bradford D. Dahms is President at Theseus Pharmaceuticals, Inc. (THRX). They have made 2 open-market trades across 1 company since 2021, most recently 2026-02-12.
CIK 0001787307
2 open-market purchases totalling $30K since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.